Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
For the nine months, sales was INR 3,978.49 million compared to INR 3,695.37 million a year ago. Revenue was INR 4,164.23 million compared to INR 3,776.43 million a year ago. Net income was INR 603.38 million compared to INR 583.31 million a year ago. Basic earnings per share from continuing operations was INR 30.12 compared to INR 29.12 a year ago. Diluted earnings per share from continuing operations was INR 30.12 compared to INR 29.12 a year ago.